Probenecid compounds for the treatment of inflammasome-mediated lung disease
Grant
US12577211B2
Kind: B2
Mar 17, 2026
Assignee
Bacainn Biotherapeutics, Ltd.
Inventors
Chris Murphy, Ronald Farquhar, Roland E. Dolle, Manuel Navia
Abstract
Disclosed herein are methods, compounds, and compositions for treating or preventing inflammasome-mediated diseases or conditions, including inflammasome-mediated lung diseases or conditions.
CPC Classifications
C07D 239/42
Filing Date
2021-06-24
Application No.
18013355
Claims
29